Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis
- PMID: 21182804
- DOI: 10.1097/OGX.0b013e3182095366
Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis
Abstract
Objective: To perform a systematic review and meta-analysis of the effectiveness of combined vitamin C and E (vitCE) supplementation for the prevention of preeclampsia.
Data sources: PubMED, Web of Science, and Cochrane Central Register of Controlled Trials from inception through June 2010, and bibliographies of review articles and eligible studies.
Methods of study selection: Fifteen eligible studies that evaluated vitCE supplementation for the prevention of preeclampsia were identified. On the basis of prespecified inclusion and exclusion criteria, 9 were included in the meta-analysis. All were randomized controlled trials. The reporting and methodologic quality of the included studies was assessed with the CONSORT checklist and the Jadad scale.
Tabulation, integration, and results: The 9 included studies had moderate-to-high CONSORT and Jadad scores. The incidence of preeclampsia was 9.7% (949 of 9833) in the vitCE group and 9.5% (946 of 9842) in the placebo group. A random effects model was used for pooling and no difference was found in the relative risk (RR) of preeclampsia between the vitCE and placebo groups (RR: 0.98; 95% confidence interval [CI]: 0.87-1.10). The incidence of gestational hypertension was 22.6% (1915 of 8491) in the vitCE group and 20.3% (1728 of 8500) in the placebo group (RR: 1.11, 95% CI: 1.05-1.17). The incidence of placental abruption was 0.58% (43 of 7379) in the vitCE group and 0.87% (64 of 7361) in the placebo group (RR: 0.67, 95% CI: 0.46-0.98). No significant differences were observed for other maternal and neonatal outcomes.
Conclusion: Combined VitCE supplementation does not decrease the risk of preeclampsia and should not be offered to gravidas for the prevention of preeclampsia or other pregnancy induced hypertensive disorders. Furthermore, combined supplementation with vitCE increased the risk of GH but decreased the risk of placental abruption. However, these latter associations may not be causal, especially since they were the product of multiple statistical comparisons, and the 95% CI around the point estimates almost included one.
Learning objectives: After completion of this educational activity, the obstetrician/gynecologist should be better able to assess the causes of preeclampsia and related conditions; evaluate and interpret the evidence regarding the use of combined vitamins C and E in prevention of preeclampsia and related conditions; and interpret and understand the effects of the supplementation of vitamins C and E for the prevention of preeclampsia or other pregnancy induced hypertensive disorders.
Target audience: Obstetricians & Gynecologists, Family Physicians.
Similar articles
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis.Am J Obstet Gynecol. 2011 Jun;204(6):503.e1-12. doi: 10.1016/j.ajog.2011.02.020. Epub 2011 May 6. Am J Obstet Gynecol. 2011. PMID: 21529757 Free PMC article. Review.
-
A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women.Hypertens Pregnancy. 2009 Aug;28(4):417-34. doi: 10.3109/10641950802629667. Hypertens Pregnancy. 2009. PMID: 19843004
-
Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review.Obstet Gynecol Surv. 2007 Mar;62(3):202-6. doi: 10.1097/01.ogx.0000256787.04807.da. Obstet Gynecol Surv. 2007. PMID: 17306042 Review.
-
Vitamins C and E and the risks of preeclampsia and perinatal complications.N Engl J Med. 2006 Apr 27;354(17):1796-806. doi: 10.1056/NEJMoa054186. N Engl J Med. 2006. PMID: 16641396 Clinical Trial.
Cited by
-
Recent Advances in the Prevention and Screening of Preeclampsia.J Clin Med. 2023 Sep 17;12(18):6020. doi: 10.3390/jcm12186020. J Clin Med. 2023. PMID: 37762960 Free PMC article. Review.
-
Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes.Adv Exp Med Biol. 2023;1428:127-148. doi: 10.1007/978-3-031-32554-0_6. Adv Exp Med Biol. 2023. PMID: 37466772 Review.
-
Nutritional Status and Nutrients Related to Pre-Eclampsia Risk.Am J Lifestyle Med. 2022 Oct 2;17(1):41-45. doi: 10.1177/15598276221129841. eCollection 2023 Jan-Feb. Am J Lifestyle Med. 2022. PMID: 36636396 Free PMC article.
-
Dietary factors that affect the risk of pre-eclampsia.BMJ Nutr Prev Health. 2022 Jun 6;5(1):118-133. doi: 10.1136/bmjnph-2021-000399. eCollection 2022. BMJ Nutr Prev Health. 2022. PMID: 35814725 Free PMC article. Review.
-
Effects of Maternal Nutritional Supplements and Dietary Interventions on Placental Complications: An Umbrella Review, Meta-Analysis and Evidence Map.Nutrients. 2021 Jan 30;13(2):472. doi: 10.3390/nu13020472. Nutrients. 2021. PMID: 33573262 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials